Clinical drug interactions in outpatients of a university hospital in Thailand

被引:15
|
作者
Janchawee, B [1 ]
Owatranporn, T
Mahatthanatrakul, W
Chongsuvivatwong, V
机构
[1] Prince Songkla Univ, Fac Sci, Dept Pharmacol, Hat Yai 90112, Thailand
[2] Prince Songkla Univ, Fac Sci, Epidemiol Unit, Hat Yai 90112, Thailand
[3] Prince Songkla Univ, Songklanagarind Hosp, Dept Pharmaceut, Hat Yai 90112, Thailand
关键词
adverse event; drug interactions; hospital; outpatients;
D O I
10.1111/j.1365-2710.2005.00688.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: A clinical event is likely to occur in patients receiving a pair of drugs, that have the potential to cause an interaction. The occurrence of a clinical drug-drug interaction in outpatients of university hospitals in Thailand is unknown. Purpose: To investigate the occurrence of a clinical event associated with drug-drug interactions in outpatients at a Thai university hospital. Methods: A case-control study was established. The case was a sample group, randomly selected from a 1-year sample of outpatient prescriptions containing 'significance-1' potential drug-drug interactions, whereas the control was from the same year but with no potential drug interactions. Medical records of the cases and the controls were reviewed for an adverse event (AE) using a newly developed review form. The odds ratio of occurrence of the AE between the cases and the controls was determined. The AE was assessed for its possibility of being caused from a drug-drug interaction. Results: The most common specific AE in both the cases and the controls was cough. An unplanned revisit to outpatient department or emergency room was found to be the most common general AE. The odds ratio of the occurrence of an AE in the cases, compared with the controls, was 1.495 (95% Cl: 0.917-2.438). The possibility that the AEs resulted from drug interactions in the case group was nine 'probable' patients and 15 'possible' patients, whereas that in the control group was eight 'possible' patients. The most common interacting drug pair was isoniazid-rifampin with an increase in serum hepatic enzymes as the corresponding AE. Conclusions: Despite outpatients receiving drug pairs with a high potential for adverse interactions, the rate of occurrence of clinical drug interaction events was low.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 50 条
  • [41] Potential drug-drug interactions associated with clinical and laboratory findings at hospital admission
    Kovacevic, Milena
    Kovacevic, Sandra Vezmar
    Radovanovic, Slavica
    Stevanovic, Predrag
    Miljkovic, Branislava
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 150 - 157
  • [42] EPIDEMIOLOGICAL STUDY OF CLINICAL SIGNIFICANCE OF DRUG-DRUG INTERACTIONS IN A PRIVATE COMMUNITY HOSPITAL
    PUCKETT, WH
    VISCONTI, JA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1971, 28 (04): : 247 - &
  • [43] Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining
    Camille Morival
    Richard Westerlynck
    Guillaume Bouzillé
    Marc Cuggia
    Pascal Le Corre
    European Journal of Clinical Pharmacology, 2018, 74 : 525 - 534
  • [44] Potential drug-drug interactions in University Hospital Medical Intensive Care Unit patients in Turkey
    Demirkapu, M. Jafarova
    Kara, S. Pinar
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (22) : 7108 - 7114
  • [45] Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining
    Morival, Camille
    Westerlynck, Richard
    Bouzille, Guillaume
    Cuggia, Marc
    Le Corre, Pascal
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 525 - 534
  • [46] Potential drug–drug interactions in pediatric wards of Gondar University Hospital,Ethiopia:A cross sectional study
    Henok Getachew
    Mohammed Assen
    Feser Dula
    Akshaya Srikanth Bhagavathula
    Asian Pacific Journal of Tropical Biomedicine, 2016, (06) : 534 - 538
  • [47] Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience
    Carmen Lopez-Martin
    Margarita Garrido Siles
    Julia Alcaide-Garcia
    Vicente Faus Felipe
    International Journal of Clinical Pharmacy, 2014, 36 : 1251 - 1259
  • [48] Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience
    Lopez-Martin, Carmen
    Garrido Siles, Margarita
    Alcaide-Garcia, Julia
    Faus Felipe, Vicente
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (06) : 1251 - 1259
  • [49] Iatrogeny and drug dispensations for outpatients: implication of a hospital pharmacy
    Degris, Emilie
    Peyranne, Isabelle
    Sarda, Anne Laure
    Malric, Nadine
    Bellon, Brigitte
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 662 - 663
  • [50] Drug-Related Hospital Readmission in Community Hospital, Thailand
    Unin, Jaruwan
    Tragulpiankit, Pramote
    Moungnoi, Chaweewan
    Channalao, Porntip
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 123 - 123